Hui Zhang, PhD

Neurocrine Biosciences, Inc., San Diego, California

  • 2Articles
  • 3.7KReads1
  • 2006–2026Active
  • 21Collaborators

1 Read counts for articles published before 2020 may include some non-human traffic.

About

Hui Zhang, PhD, is affiliated with Neurocrine Biosciences, Inc. in San Diego, California. Zhang has published research focusing on metabolic disorders, schizophrenia and schizoaffective disorders, and tardive dyskinesia. Notable work includes validation of patient-reported outcome measures for tardive dyskinesia and studies on glucose metabolism in patients with schizophrenia treated with antipsychotics. Zhang has collaborated frequently with co-authors such as A. Eden Evins and Christoph U. Correll.

Publications

JCP
Validation for the Tardive Dyskinesia Impact Scale, a Patient-Reported Outcome Measure in Valbenazine Clinical Trials
JCP

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.